Not all individuals with CLL require therapy. Despite all modern developments, the iwCLL still endorses watchful observation for clients with asymptomatic disorder.86 This recommendation is based on at the least two randomized trials evaluating observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).復